Trial Profile
A randomized, double-blind study of GT267-004 versus vancomycin, and GT267-004 versus metronidazole in patients with C. difficile-associated diarrhea
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Sep 2021
Price :
$35
*
At a glance
- Drugs Tolevamer (Primary) ; Metronidazole; Vancomycin
- Indications Clostridium difficile infections; Diarrhoea
- Focus Registrational; Therapeutic Use
- Acronyms PACT
- Sponsors Genzyme Europe; Sanofi
- 09 Nov 2012 Lead trial centre identified as reported by EudraCT.
- 19 Apr 2008 Results presented at ECCMID 2008
- 17 Aug 2007 Status changed from in progress to completed.